Ocrelizumab, sold under the brand name Ocrevus, is a medication used for the treatment of multiple sclerosis. It is a humanized anti-CD20 monoclonal antibody...

Ocrelizumab/hyaluronidase, sold under the brand name Ocrevus Zunovo, is a fixed-dose combination medication used for the treatment of multiple sclerosis...

approved medications continue to emerge. In March 2017, the FDA approved ocrelizumab as a treatment for primary progressive MS in adults, the first drug to...

Research (2020-01-24). "New Drug Therapy Approvals 2019". FDA. "Ocrevus (ocrelizumab) Injection". www.accessdata.fda.gov. Retrieved 2021-07-01. "Search Orphan...

monoclonal treatment, in managing this disease, other anti-CD20 drugs such as ocrelizumab, veltuzumab, and ofatumumab have been explored as potential treatments...

and their approval status: CD20 is the target of the mAbs rituximab, ocrelizumab, obinutuzumab, ofatumumab, ibritumomab tiuxetan, tositumomab, and ublituximab...

deficiency, later discontinued in 2004 and replaced by Nutropin AQ. Ocrevus (ocrelizumab), for MS. Peginterferon/alfa-2a|Pegasys]], (peginterferon alfa-2a) for...

of generalized myasthenia gravis in the United States in June 2023. Ocrelizumab/hyaluronidase-ocsq (Ocrevus Zunovo) was approved for medical use in the...

in England, Wales and Northern Ireland will be offered injections of ocrelizumab, which can slow the progress of the disease. Princess Anne returns to...

cancer indication due to promising phase II results. 2017: Ocrevus (ocrelizumab): The first FDA-approved therapy that treats both relapsing-remitting...

GlaxoSmithKline recurrent ovarian cancer responsive to platinum-based chemotherapy Ocrelizumab Genentech multiple sclerosis Dupilumab Regeneron Pharmaceuticals atopic...

ocaperidone (INN) ocfentanil (INN) ociltide (INN) ocinaplon (INN) ocrase (INN) ocrelizumab (INN) Ocrevus Ocrevus Zunovo ocrilate (INN) ocriplasmin (INN) octabenzone...

Y chronic lymphatic leukemia Ocaratuzumab mab humanized CD20 cancer Ocrelizumab Ocrevus mab humanized CD20 Y multiple sclerosis Odesivimab mab human...

Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Patients With Primary Progressive Multiple Sclerosis" at ClinicalTrials...

Letolizumab Ligelizumab† Lulizumab pegol Mepolizumab Mogamulizumab Natalizumab Ocrelizumab (+hyaluronidase) Omalizumab Ozoralizumab Pascolizumab Pateclizumab Pembrolizumab...

has led to some other anti-CD20 monoclonal antibodies being developed: ocrelizumab, humanized (90%-95% human) B cell-depleting agent. ofatumumab (HuMax-CD20)...

anti-CD20 monoclonal antibody, has been approved for some indications. Ocrelizumab, ofatumumab, and "third-generation" anti-CD20 monoclonals are in development...

Keliximab Zanolimumab CD11a Efalizumab CD18 Erlizumab CD20 Obinutuzumab Ocrelizumab (+hyaluronidase) Pascolizumab Rituximab Ublituximab CD23 Gomiliximab...

monoclonal antibodies: Alemtuzumab (Lemtrada, Campath). Natalizumab (Tysabri) Ocrelizumab (Ocrevus) which is also approved for primary progressive (PPMS) Ofatumumab...

intravenous humanized CD20 Chronic lymphocytic leukemia 125486 Link ocrelizumab Ocrevus Genentech 3/28/2017 intravenous humanized CD20 Multiple sclerosis...

Belimumab L04AG05 Vedolizumab L04AG06 Alemtuzumab L04AG07 Begelomab L04AG08 Ocrelizumab L04AG09 Emapalumab L04AG10 Inebilizumab L04AG11 Anifrolumab L04AG12 Ofatumumab...

several more in development. Similarly, anti-CD20 monoclonal antibody Ocrelizumab is in trials for multiple sclerosis. CD21 CR2, a type I transmembrane...

beta-1a and beta-1b; monoclonal antibodies: natalizumab, alemtuzumab, ocrelizumab, ofatumumab, and ublituximab; and immunomodulators: glatiramer acetate...

treatment for diseases such as multiple sclerosis and optic neuritis. Ocrelizumab "Biogen MS Drug Results Are 'Mildly Encouraging' In Eye Disease Test"...

clinical trial with a fully humanized anti-CD20 monoclonal antibody, ocrelizumab, replicated the results of the rituximab trial in relapsing remitting...

multiple sclerosis, becomes the person in the UK to receive the drug ocrelizumab. 11 September – The UK government has agreed to give Tata Steel £500m...

Letolizumab Ligelizumab† Lulizumab pegol Mepolizumab Mogamulizumab Natalizumab Ocrelizumab (+hyaluronidase) Omalizumab Ozoralizumab Pascolizumab Pateclizumab Pembrolizumab...

Keliximab Zanolimumab CD11a Efalizumab CD18 Erlizumab CD20 Obinutuzumab Ocrelizumab (+hyaluronidase) Pascolizumab Rituximab Ublituximab CD23 Gomiliximab...

remissions. There is currently only one approved medication for PPMS—Ocrevus (Ocrelizumab). In 2006, DaSilva decided to document his challenges as a filmmaker...

CSF Biomarkers in Primary Progressive MS and Relapsing MS in the OBOE (Ocrelizumab Biomarker Outcome Evaluation) Trial (1635). Amit Bar-Or, Jeffrey Bennett...